TipRanks
Advertisement
Advertisement

GB:0R0T Stock Latest News

Amgen: Neutral Stance Maintained as Long-Term Pipeline Offsets Near-Term Uncertainty; Price Target Reaffirmed at $405
RatingsAmgen: Neutral Stance Maintained as Long-Term Pipeline Offsets Near-Term Uncertainty; Price Target Reaffirmed at $405
13h ago
AMGN
Analyst Maintains Buy on Amgen, Citing Resilient Fundamentals, Strong Execution, and Late-Stage Pipeline Upside
PremiumRatings
Analyst Maintains Buy on Amgen, Citing Resilient Fundamentals, Strong Execution, and Late-Stage Pipeline Upside
1d ago
AMGN
Amgen to deploy Veeva Vault CRM globally
PremiumThe Fly
Amgen to deploy Veeva Vault CRM globally
2d ago
AMGN
VEEV
Amgen says FDA approves update to imdelltra Prescribing Information
PremiumThe Fly
Amgen says FDA approves update to imdelltra Prescribing Information
3d ago
AMGN
Meta upgraded, Nvidia initiated: Wall Street’s top analyst calls
PremiumThe Fly
Meta upgraded, Nvidia initiated: Wall Street’s top analyst calls
7d ago
AS
UA
HSBC downgrades Amgen to Hold on fair value after re-rating
PremiumThe FlyHSBC downgrades Amgen to Hold on fair value after re-rating
8d ago
AMGN
Amgen downgraded to Hold from Buy at HSBC
Premium
The Fly
Amgen downgraded to Hold from Buy at HSBC
8d ago
AMGN
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
Premium
Ratings
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
9d ago
AMGN
SpaceX initiated, Intel upgraded: Wall Street’s top analyst calls
PremiumThe Fly
SpaceX initiated, Intel upgraded: Wall Street’s top analyst calls
9d ago
BBY
LMT
Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint
PremiumThe Fly
Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint
9d ago
AZN
AMGN
AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab
PremiumThe Fly
AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab
9d ago
AZN
AMGN
Amgen downgraded to Market Perform from Outperform at BMO Capital
PremiumThe Fly
Amgen downgraded to Market Perform from Outperform at BMO Capital
10d ago
AMGN
Novartis pelacarsen miss ‘not great on the margin for’ Amgen, says UBS
PremiumThe FlyNovartis pelacarsen miss ‘not great on the margin for’ Amgen, says UBS
10d ago
NVS
AMGN
Amgen price target raised to $435 from $400 at Wells Fargo
Premium
The Fly
Amgen price target raised to $435 from $400 at Wells Fargo
13d ago
AMGN
Amgen price target raised to $435 from $400 at Wells Fargo
Premium
The Fly
Amgen price target raised to $435 from $400 at Wells Fargo
14d ago
AMGN
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
PremiumTipRanks Newswire
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
17d ago
LLY
NVO
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
PremiumThe Fly
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
18d ago
AMGN
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
PremiumThe Fly
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
21d ago
AZN
AMGN
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
PremiumThe Fly
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
22d ago
AZN
AMGN
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
PremiumThe FlyTrump Trade: Canada rolls out 50% tariffs on U.S. metals
22d ago
AA
MT
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
Premium
The Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
23d ago
ABT
BMY
Amgen price target raised to $457 from $427 at Piper Sandler
Premium
The Fly
Amgen price target raised to $457 from $427 at Piper Sandler
28d ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >